Historical salary details - Dr. Beth C. Seidenberg,M.D., Independent Director, Vera Therapeutics Inc - Ordinary Shares - Class A
Dr. Beth C. Seidenberg,M.D. is the Independent Director of Vera Therapeutics Inc - Ordinary Shares - Class A. They also hold 3 other positions in Kyverna Therapeutics Inc., Acelyrin Inc and Sagimet Biosciences Inc - Ordinary Shares - Class A.
Dr. Beth C. Seidenberg,M.D.
Independent Director
$ 491.5 K
Gross Remuneration
-
Current Company
Vera Therapeutics Inc - Ordinary Shares - Class A
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Vera Therapeutics Inc - Ordinary Shares - Class A | Independent Director | 436.6 K | - |
| 2024 | Kyverna Therapeutics Inc. | Independent Director | 55.0 K | -64.6 % |
| 2024 | Acelyrin Inc | Independent Director | - | - |
| 2024 | Sagimet Biosciences Inc - Ordinary Shares - Class A | Independent Director | - | - |
| 2023 | Progyny Inc | Lead Independent Director | 653.4 K | 16.7 % |
| 2023 | Acelyrin Inc | - | 349.5 K | - |
| 2023 | Kyverna Therapeutics Inc. | Independent Director | 155.1 K | - |
| 2023 | Atara Biotherapeutics Inc | Independent Director | 25 K | -93.0 % |
| 2023 | Sagimet Biosciences Inc - Ordinary Shares - Class A | - | 14.4 K | - |
| 2022 | Progyny Inc | Lead Independent Director | 559.8 K | -19.2 % |
| 2022 | Atara Biotherapeutics Inc | Independent Director | 355.3 K | -0.9 % |
| 2022 | Acelyrin Inc | Independent Director | - | - |
| 2022 | Vera Therapeutics Inc - Ordinary Shares - Class A | Independent Director | - | - |
| 2022 | Sagimet Biosciences Inc - Ordinary Shares - Class A | Independent Director | - | - |
| 2021 | Progyny Inc | Lead Independent Director | 692.7 K | 6.0 % |
| 2021 | Atara Biotherapeutics Inc | Independent Director | 358.5 K | 17.1 % |
| 2021 | Vera Therapeutics Inc - Ordinary Shares - Class A | Independent Director | 93.4 K | -46.0 % |
| 2020 | Progyny Inc | Chairman of the Board | 653.4 K | 385.0 % |
| 2020 | Atara Biotherapeutics Inc | Independent Director | 306.0 K | 1.2 % |
| 2020 | Vera Therapeutics Inc - Ordinary Shares - Class A | Independent Director | 172.9 K | - |
| 2019 | Atara Biotherapeutics Inc | Independent Director | 302.5 K | 22.6 % |
| 2019 | Progyny Inc | Chairman of the Board | 134.7 K | - |
| 2018 | Atara Biotherapeutics Inc | Independent Director | 246.8 K | -23.6 % |
| 2018 | Progyny Inc | Chairman of the Board | - | - |
| 2017 | Atara Biotherapeutics Inc | Independent Director | 322.9 K | 71.6 % |
| 2016 | Atara Biotherapeutics Inc | Independent Director | 188.1 K | -52.6 % |
| 2015 | Atara Biotherapeutics Inc | Independent Director | 397.1 K | 3594.2 % |
| 2014 | Atara Biotherapeutics Inc | Independent Director | 10.8 K | - |
| 2013 | Atara Biotherapeutics Inc | Independent Director | - | - |
| 2011 | Biocryst Pharmaceuticals Inc. | - | 4 K | -95.7 % |
| 2011 | Biocryst Pharmaceuticals Inc. | Independent Director | - | - |
| 2010 | Biocryst Pharmaceuticals Inc. | Independent Director | 93.2 K | 31.1 % |
| 2009 | Biocryst Pharmaceuticals Inc. | Director | 71.1 K | - |
| 2008 | Biocryst Pharmaceuticals Inc. | - | 43.6 K | -65.2 % |
| 2008 | Biocryst Pharmaceuticals Inc. | Director | - | - |
| 2007 | Biocryst Pharmaceuticals Inc. | Director | 125.2 K | -16.8 % |
| 2006 | Biocryst Pharmaceuticals Inc. | Director | 150.4 K | - |
| 2005 | Biocryst Pharmaceuticals Inc. | Director | - | - |
| 2004 | Biocryst Pharmaceuticals Inc. | Director | - | - |